- Home
- NMTC vs ACCS Comparison
NMTC vs ACCS Comparison
Compare NMTC & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- ACCS
- Stock Information
- Founded
- NMTC 2009
- ACCS 1988
- Country
- NMTC United States
- ACCS United States
- Employees
- NMTC N/A
- ACCS N/A
- Industry
- NMTC Medical/Dental Instruments
- ACCS Publishing
- Sector
- NMTC Health Care
- ACCS Consumer Discretionary
- Exchange
- NMTC Nasdaq
- ACCS Nasdaq
- Market Cap
- NMTC 45.0M
- ACCS 42.6M
- IPO Year
- NMTC N/A
- ACCS N/A
- Fundamental
- Price
- NMTC $1.06
- ACCS $10.46
- Analyst Decision
- NMTC Strong Buy
- ACCS Strong Buy
- Analyst Count
- NMTC 2
- ACCS 1
- Target Price
- NMTC $2.23
- ACCS $14.00
- AVG Volume (30 Days)
- NMTC 505.0K
- ACCS 5.5K
- Earning Date
- NMTC 08-14-2025
- ACCS 11-06-2025
- Dividend Yield
- NMTC N/A
- ACCS N/A
- EPS Growth
- NMTC N/A
- ACCS N/A
- EPS
- NMTC N/A
- ACCS N/A
- Revenue
- NMTC $6,629,051.00
- ACCS $22,562,000.00
- Revenue This Year
- NMTC $151.98
- ACCS $0.03
- Revenue Next Year
- NMTC $31.96
- ACCS $11.45
- P/E Ratio
- NMTC N/A
- ACCS N/A
- Revenue Growth
- NMTC 69.00
- ACCS 26.44
- 52 Week Low
- NMTC $0.40
- ACCS $7.79
- 52 Week High
- NMTC $1.39
- ACCS $13.35
- Technical
- Relative Strength Index (RSI)
- NMTC 73.51
- ACCS 42.43
- Support Level
- NMTC $0.87
- ACCS $10.49
- Resistance Level
- NMTC $0.95
- ACCS $10.90
- Average True Range (ATR)
- NMTC 0.07
- ACCS 0.50
- MACD
- NMTC 0.01
- ACCS 0.01
- Stochastic Oscillator
- NMTC 72.06
- ACCS 62.13
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.